UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
AMICUS THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
| Delaware organization) |
20-0422823 |
6
Cedar Brook Drive, Cranbury, NJ
08512
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
| Title of each class to be so registered |
Name of each exchange on
which each class is to be registered |
|||
| Common Stock, $0.01 par value | The NASDAQ Stock Market LLC |
| If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. þ | If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o |
Securities Act registration statement file number to
which this form
relates: File No. 333-141700
(if applicable)
(Title of Class)
ITEM 1. DESCRIPTION
OF REGISTRANT’S SECURITIES TO BE REGISTERED.
See
the “Description of Capital Stock” section in the prospectus included in the Registration
Statement on Form S-1 (File No. 333-141700) of Amicus
Therapeutics, Inc. (the “Registrant”), initially filed with the Securities and
Exchange Commission on March 30, 2007, including any subsequent amendments
thereto, which section is hereby incorporated by reference herein.
ITEM 2. EXHIBITS.
Under the
Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be
filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC
and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURES
Pursuant to the
requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has
duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMICUS THERAPEUTICS, INC. |
|||||
| By: | /s/ Douglas A. Branch | ||||
| Douglas A.
Branch, Esq. Vice President and General Counsel |
|||||
Date: May 23, 2007